[Immunotherapy for malignant glioblastoma].
Nose
T
T
Department of Neurological Surgery, University of Tsukuba.
Nakagawa
K
K
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000628:therapy*; D016207:Cytokines / Q000235:genetics; D015316:Genetic Therapy / Q000379:methods; D005909:Glioblastoma / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
D000911:Antibodies, Monoclonal; D016207:Cytokines